Certain topical pain relief products could potentially lead to dangerous health effects, according to the U.S. Food and Drug Administration. In a warning issued by the agency on March 26, some ...

Chronic pain is a pretty common ailment that can affect your lifestyle, mood, and mobility. Luckily, CBD products can actually give you some relief. CBD help in reducing discomfort and chronic pain — ...

STATEN ISLAND, N.Y.-- The U.S Food and Drug Administration (FDA) is telling customers to avoid topical pain relief products from six companies. The products these companies make are usually marketed ...

The FDA is warning consumers to avoid over-the-counter topical pain relief products that contain high concentrations of lidocaine and has sent warning letters to six companies marketing unapproved ...

Add Yahoo as a preferred source to see more of our stories on Google. Whether it be nagging muscle pain, persistent back pain, or sore and tight joints, it’s no fun being in discomfort. However, ...

“It’s complicated because cannabis products are complicated,” said lead author of the study, Roger Chou, M.D., senior adviser for the Pacific Northwest Evidence-based Practice Center at Oregon Health ...

Whether you’re suffering from pain related to an injury, an autoimmune disease, or neuropathy from conditions such as diabetes, you may be interested in trying out dietary supplements such as ...

There is no evidence that CBD products reduce chronic pain, and taking them is a waste of money and potentially harmful to health, according to new research led by the University of Bath in the UK.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Of 182 patients treated at an orthopedic sports medicine ...

Please provide your email address to receive an email when new articles are posted on . FDA testing found products to contain ingredients not listed on the product label. These types of products may ...

The good news is sciatica is usually completely treatable.

The incidence of several types of chronic and acute pain will increase significantly over the next few years, driving growth in transdermal pain products to reach $9.2 billion in 2015, according to a ...